EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma

Ricardo Santiago Gomez, Ahmed El Mouatani, Filipe Fideles Duarte-Andrade, Thais Dos Santos Fontes Pereira, Letícia Martins Guimarães, Tenzin Gayden, Damien Faury, Emily M Nakada, Sylvie Langlois, Daniel Sinnett, Wagner Henriques de Castro, Marina Gonçalves Diniz und 2 weitere

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2023.100388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Ricardo Santiago Gomez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery and Pathology, Faculty of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil; Medical School, …. Hauptthemen laut MEDLINE: Cementoma, Fibroma, Ossifying, Odontogenic Tumors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: CAPES, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cemento-ossifying fibroma (COF) of the jaws is currently classified as a benign mesenchymal odontogenic tumor, and only targeted approaches have been used to assess its genetic alterations. A minimal proportion of COFs harbor CDC73 somatic mutations, and copy number alterations (CNAs) involving chromosomes 7 and 12 have recently been reported in a small proportion of cases. However, the genetic background of COFs remains obscure. We used a combination of whole-exome sequencing and RNA sequencing to assess somatic mutations, fusion transcripts, and CNAs in a cohort of 12 freshly collected COFs. No recurrent fusions have been identified among the 5 cases successfully analyzed by RNA sequencing, with in-frame fusions being detected in 2 cases (MARS1::GOLT1B and PARG::BMS1 in one case and NCLN::FZR1 and NFIC::SAMD1 in the other case) and no candidate fusions identified for the remaining 3 cases. No recurrent pathogenic mutations were detected in the 11 cases that had undergone whole-exome sequencing. A KRAS p.L19F missense variant was detected in one case, and 2 CDC73 deletions were detected in another case. The other variants were of uncertain significance and included variants in PC, ACTB, DOK6, HACE1, and COL1A2 and previously unreported variants in PTPN14, ATP5F1C, APOBEC1, HDAC5, ATF7IP, PARP2, and ACTR3B. The affected genes do not clearly converge on any signaling pathway. CNAs were detected in 5/11 cases (45%), with copy gains involving chromosome 12 occurring in 3/11 cases (27%). In conclusion, no recurrent fusions or pathogenic variants have been detected in the present COF cohort, with copy gains involving chromosome 12 occurring in 27% of cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CementomaFibroma, OssifyingOdontogenic TumorsHumansGenomicsProtein Tyrosine Phosphatases, Non-ReceptorAdaptor Proteins, Signal TransducingUbiquitin-Protein Ligases

Stichwörter der Autor:innen

RNAseqcopy number alterationfibro-osseous lesiongene fusionsgeneticsossifying fibromawhole-exome sequencing

Substanzen

PTPN14 protein, humanProtein Tyrosine Phosphatases, Non-ReceptorDOK6 protein, humanAdaptor Proteins, Signal TransducingHACE1 protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Oral Surgery and Pathology, Faculty of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil; Medical School, Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil. El…
  • Department of Human Genetics, McGill University, Montreal, Canada.
  • Department of Oral Surgery and Pathology, Faculty of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Department of Human Genetics, McGill University, Montreal, Canada; Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Department of Pediatrics, McGill University and the Research Institute of the McGill University Health Centre, Montreal, Canada.
  • Division of Hematology-Oncology, Research Center, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.

Förderung

  • CAPES
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Zitieren

APA

Gomez, R. S., El Mouatani, A., Duarte-Andrade, F. F., Pereira, T. D. S. F., Guimarães, L. M., Gayden, T., Faury, D., Nakada, E. M., Langlois, S., Sinnett, D., de Castro, W. H., Diniz, M. G., Jabado, N., & Gomes, C. C. (2024). Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100388

Vancouver

Gomez RS, El Mouatani A, Duarte-Andrade FF, Pereira TDSF, Guimarães LM, Gayden T, et al. Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma. Modern Pathology. 2024. doi:10.1016/j.modpat.2023.100388

BibTeX
@article{Gomez2024,
  author = {Gomez, Ricardo Santiago and El Mouatani, Ahmed and Duarte-Andrade, Filipe Fideles and Pereira, Thais Dos Santos Fontes and Guimarães, Letícia Martins and Gayden, Tenzin and Faury, Damien and Nakada, Emily M and Langlois, Sylvie and Sinnett, Daniel and de Castro, Wagner Henriques and Diniz, Marina Gonçalves and Jabado, Nada and Gomes, Carolina Cavalieri},
  title = {Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2023.100388}
}
Kostenlos starten →